HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tong Wu Selected Research

Proto-Oncogene Proteins c-vav

1/2022Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tong Wu Research Topics

Disease

133Neoplasms (Cancer)
02/2022 - 08/2002
44Inflammation (Inflammations)
08/2022 - 01/2004
29Infections
12/2022 - 09/2002
25Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2002
23Cholangiocarcinoma
03/2022 - 08/2002
21Breast Neoplasms (Breast Cancer)
02/2022 - 09/2013
17Leukemia
11/2021 - 06/2003
16Carcinogenesis
01/2022 - 10/2004
15Neoplasm Metastasis (Metastasis)
02/2022 - 10/2013
14Obesity
01/2022 - 04/2002
13Wounds and Injuries (Trauma)
05/2022 - 02/2008
12Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2014
12Fibrosis (Cirrhosis)
06/2021 - 02/2015
10Lung Neoplasms (Lung Cancer)
07/2022 - 07/2011
10Insulin Resistance
01/2021 - 08/2003
8Body Weight (Weight, Body)
11/2021 - 09/2009
8Liver Diseases (Liver Disease)
06/2021 - 12/2008
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 01/2014
7Pain (Aches)
01/2021 - 01/2014
7Liver Neoplasms (Liver Cancer)
01/2020 - 09/2003
6COVID-19
12/2022 - 01/2020
6Sarcoma (Soft Tissue Sarcoma)
03/2022 - 01/2020
6Atherosclerosis
01/2021 - 04/2002
5Stroke (Strokes)
08/2022 - 12/2018
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 05/2016
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2022 - 02/2004
5Glioma (Gliomas)
01/2022 - 04/2016
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 12/2010
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2015
5Necrosis
01/2020 - 10/2006
4Sepsis (Septicemia)
06/2022 - 01/2020
4Type 2 Diabetes Mellitus (MODY)
02/2022 - 12/2019
4Osteoarthritis
02/2022 - 01/2013
4Hypoxia (Hypoxemia)
01/2022 - 01/2020
4Virus Diseases (Viral Diseases)
01/2022 - 11/2013
4Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 04/2006
4Carcinoma (Carcinomatosis)
10/2021 - 10/2014
4Adenocarcinoma of Lung
12/2019 - 12/2015
4Diabetes Mellitus
01/2017 - 04/2002

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2013
30Biological ProductsIBA
02/2021 - 07/2003
25Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2017
17Pharmaceutical PreparationsIBA
08/2022 - 01/2010
15LipidsIBA
01/2022 - 04/2002
13Messenger RNA (mRNA)IBA
05/2022 - 06/2003
13Dinoprostone (PGE2)FDA Link
01/2021 - 10/2004
13Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2014 - 08/2002
12MicroRNAs (MicroRNA)IBA
02/2022 - 07/2012
12CytokinesIBA
01/2022 - 01/2004
12EnzymesIBA
01/2022 - 04/2002
11Long Noncoding RNAIBA
01/2022 - 10/2018
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2003
9Docosahexaenoic AcidsIBA
01/2018 - 01/2008
9ProstaglandinsIBA
09/2009 - 08/2002
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2002
8LigandsIBA
01/2022 - 07/2003
715-hydroxyprostaglandin dehydrogenaseIBA
03/2022 - 01/2008
7Antiviral Agents (Antivirals)IBA
12/2021 - 08/2006
7RNA (Ribonucleic Acid)IBA
01/2021 - 01/2011
7Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2015 - 01/2008
6ElementsIBA
03/2022 - 12/2010
6Interleukin-6 (Interleukin 6)IBA
01/2022 - 08/2002
6Peptides (Polypeptides)IBA
01/2022 - 01/2019
6AntigensIBA
01/2022 - 12/2010
6Fatty Acids (Saturated Fatty Acids)IBA
10/2021 - 01/2011
6Small Interfering RNA (siRNA)IBA
05/2021 - 06/2005
6Prostaglandins EIBA
02/2008 - 08/2002
5Phenobarbital (Luminal)FDA Link
02/2022 - 09/2013
5Alanine Transaminase (SGPT)IBA
01/2022 - 12/2008
5Fibronectins (Fibronectin)IBA
01/2022 - 01/2020
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022 - 12/2008
5ChemokinesIBA
01/2022 - 03/2016
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 06/2005
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
5Metal-Organic FrameworksIBA
12/2021 - 01/2020
5CholesterolIBA
12/2021 - 02/2010
5AntioxidantsIBA
11/2021 - 01/2020
5Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 05/2014
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2020 - 04/2002
5Phosphotransferases (Kinase)IBA
12/2020 - 04/2006
5InterferonsIBA
01/2020 - 01/2011
5beta CateninIBA
01/2011 - 01/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2013
4CateninsIBA
01/2022 - 01/2011
4ZincIBA
12/2021 - 07/2011
4Mitochondrial DNA (mtDNA)IBA
12/2021 - 10/2017
4Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2021 - 08/2006
4MicellesIBA
11/2021 - 07/2016
4Arachidonic Acid (Vitamin F)IBA
06/2021 - 01/2004
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2020 - 08/2002
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2012 - 08/2004

Therapy/Procedure

50Therapeutics
02/2022 - 08/2006
19Drug Therapy (Chemotherapy)
01/2022 - 07/2005
15Transplantation
04/2022 - 09/2003
14Hematopoietic Stem Cell Transplantation
11/2021 - 02/2004
10Immunotherapy
01/2022 - 06/2012
7Chemoprevention
08/2016 - 07/2005
6Radiotherapy
02/2021 - 07/2005
4Photochemotherapy (Photodynamic Therapy)
12/2021 - 10/2017
4Stem Cell Transplantation
01/2020 - 06/2008